tm logo
SINTBILO
Live/Registered
REGISTERED

on 30 Nov 2021

Last Applicant/ Owned by

Suzhou Industrial Park

Suzhou City

CN

215123

Serial Number

90160122 filed on 04th Sep 2020

Registration Number

6572234 registered on 30th Nov 2021

in the Principal Register

Correspondent Address

Anessa Owen Kramer

HONIGMAN LLP

39400 WOODWARD AVENUE, SUITE 101

BLOOMFIELD HILLS, MI, , 48304-5151

Filing Basis

1. intent to use

Disclaimer

NO DATA

SINTBILO

The mark consists of a circle from which thirteen rounded shapes protrude, two such shapes appearing to drift off to the left, with one small circle appearing above and to the left of the larger circle, with the word "SINTBILO" appearing to the right. Pharmaceutical preparations, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood dRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; vaccines; drugs in the nature of pharmaceutical preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; biological preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; medicines for human purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; pharmaceuticals contained in syringe for treating cancer or tumor; chemical preparations for medical purposes, namely, preparations used for treating tumor, ophthalmology diseases, cardiovascular diseases immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, and antivirals; dietetic foods adapted for medical use; biological preparations for veterinary purposes for the treatment of tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer and antivirals; diagnostic preparations for medical purposes

Mark Details


Serial Number

No 90160122

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

05.01.25 -

Other trees or bushes

05.05.05 -

Daisies, sunflowers, dandelions

26.01.02 -

Plain single line circles

26.01.21 -

Circles that are totally or partially shaded

26.01.31 -

Five or more circles

26.17.01 -

Straight line(s), band(s) or bar(s)

26.17.04 -

Vertical line(s), band(s) or bar(s)

Description of Design Search

The mark consists of a circle from which thirteen rounded shapes protrude, two such shapes appearing to drift off to the left, with one small circle appearing above and to the left of the larger circle, with the word "SINTBILO" appearing to the right.

Legal History


Show more

Status DateAction Taken
30th Nov 2021REGISTERED-PRINCIPAL REGISTER
14th Sep 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14th Sep 2021PUBLISHED FOR OPPOSITION
26th Aug 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06th Aug 2021APPROVED FOR PUB - PRINCIPAL REGISTER
06th Aug 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06th Aug 2021EXAMINER'S AMENDMENT ENTERED
06th Aug 2021EXAMINERS AMENDMENT E-MAILED
06th Aug 2021EXAMINERS AMENDMENT -WRITTEN
23rd Jul 2021ASSIGNED TO LIE